ArticleScientific reports2024
Neuron-level explainable AI for Alzheimer's Disease assessment from fundus images.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.
- Multimodal AI for Alzheimer Disease Diagnosis: Systematic Review of Datasets, Models, and Modalities.Journal of medical Internet research · 2026Pooled it
- Frontotemporal dementia: a systematic review of artificial intelligence approaches in differential diagnosis.Frontiers in aging neuroscience · 2025Pooled it
- Review
- On the prediction models for brain signal-based emotion recognition.Scientific reports · 2026Article
- Evaluating Homoscedastic Uncertainty Weighting and Generative Tau Imputation in a Multimodal, Multitask Deep Learning Framework for Alzheimer's Disease.Neuroinformatics · 2026Article
- Use of explainable AI (xAI) in dementia detection and prognosis: a scoping review.BMC medical informatics and decision making · 2026Article
- AI-powered oculomics for early diagnosis of neurodegenerative diseases through retinal microvasculature analysis.Annals of medicine and surgery (2012) · 2026Article
- A Hybrid Explainable AI Framework (HXAI) for Accurate and Interpretable Diagnosis of Alzheimer's Disease.Diagnostics (Basel, Switzerland) · 2025Article
- The Eye as a Window to Brain Health: Can Retinal Imaging and AI Modeling Predict Alzheimer's Disease?Brain and behavior · 2025Review
- A Feature-Augmented Explainable Artificial Intelligence Model for Diagnosing Alzheimer's Disease from Multimodal Clinical and Neuroimaging Data.Diagnostics (Basel, Switzerland) · 2025Article
- An explainable transformer model for Alzheimer's disease detection using retinal imaging.Scientific reports · 2025Article
- A Meta-Learning-Based Ensemble Model for Explainable Alzheimer's Disease Diagnosis.Diagnostics (Basel, Switzerland) · 2025Article
- AI-assisted ophthalmic imaging for early detection of neurodegenerative diseases.International journal of emergency medicine · 2025Review
- Validation of neuron activation patterns for artificial intelligence models in oculomics.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
Alzheimer's Disease (AD) is a progressive neurodegenerative disease and the leading cause of dementia. Early diagnosis is critical for patients to benefit from potential intervention and treatment. The retina has emerged as a plausible diagnostic site for AD detection owing to its anatomical connection with the brain. However, existing AI models for this purpose have yet to provide a rational explanation behind their decisions and have not been able to infer the stage of the disease's progression. Along this direction, we propose a novel model-agnostic explainable-AI framework, called Granu
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.